Watch PETS. Know when insiders buy.
One email the day a filing lands. Free.
PETS
PETMED EXPRESS INC
1.22
−0.02 −1.61%
USD · close Nov 6
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
23
FLAG · shorts 23
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $26.4MP/E —DIV YIELD —FCF YIELD -105.01%REV TTM $168.9M −20.3%NET INCOME −$29.3MNET CASH —52W 1.15 – 3.90SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $41M | −19.9% | 27.6% | −$6.2M | −$6.1M | — | -0.28 | −$7.7M | $641K | −$8.3M | Aug 13 |
| Q4 2026 · Mar 31derived | $42.8M | −15.6% | 32.6% | −$5.7M | −$4.1M | — | -0.19 | −$4.7M | $720K | −$5.5M | Jun 2 |
| Q3 2026 · Dec 31 | $40.7M | −21.7% | 23.3% | −$10.5M | −$10.6M | — | -0.50 | −$9.2M | −$21K | −$9.2M | Feb 5 |
| Q2 2026 · Sep 30 | $44.4M | −23.6% | 28.0% | −$8.4M | −$8.5M | −466.3% | -0.41 | −$2.2M | $2.6M | −$4.8M | Dec 19 |
| Q1 2026 · Jun 30 | $51.2M | −22.7% | 28.1% | −$34.1M | −$34.2M | −1009.7% | -1.65 | −$12.3M | $1.3M | −$13.6M | Aug 13 |
| Q4 2025 · Mar 31derived | $50.8M | −22.0% | 29.9% | −$6M | −$11.6M | — | -0.56 | $7M | $2.4M | $4.6M | Jun 2 |
| Q3 2025 · Dec 31 | $52M | −18.4% | 31.0% | −$450K | −$707K | — | -0.03 | −$1.2M | $777K | −$1.9M | Feb 5 |
| Q2 2025 · Sep 30 | $58M | −16.4% | 32.3% | $554K | $2.3M | +225.3% | 0.11 | $7.4M | $1.3M | $6.1M | Dec 19 |
| Q1 2025 · Jun 30 | $66.2M | — | 28.8% | $4.4M | $3.8M | — | 0.18 | −$8.5M | $683K | −$9.2M | Dec 19 |
| Q4 2024 · Mar 31derived | $65.1M | — | 29.3% | −$3.8M | −$5M | — | -0.25 | $7.1M | $1.3M | $5.9M | Jun 2 |
| Q3 2024 · Dec 31 | $63.7M | — | 30.5% | −$3.1M | −$2M | — | -0.10 | −$2.6M | $1.1M | −$3.7M | Oct 14 |
| Q2 2024 · Sep 30 | $69.5M | — | 30.6% | $875K | $715K | — | 0.03 | −$777K | $984K | −$1.8M | Jun 2 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $179M | 28.1% | −$58.7M | −$57.3M | -32.0% | -2.74 | −$28.4M | $4.6M | −$33M | — | $21K |
| FY2025 · to Mar 31 | $227M | 30.5% | −$1.5M | −$6.3M | -2.8% | -0.30 | $4.7M | $5.1M | −$395K | — | $181K |
| FY2024 · to Mar 31 | $274.1M | 30.9% | −$8.2M | −$7.5M | -2.7% | -0.37 | $4.3M | $4.5M | −$194K | — | $12.4M |
| FY2023 · to Mar 31 | $247.6M | 30.9% | $6.1M | $5.1M | 2.1% | 0.25 | $27.8M | $5.3M | $22.5M | — | $24.5M |
| FY2022 · to Mar 31 | — | — | $24.3M | $18.7M | — | 0.92 | $18.5M | $1.8M | $16.7M | $0 | $24.4M |
| FY2021 · to Mar 31 | — | — | $30.5M | $23.9M | — | 1.19 | $40.1M | $2.4M | $37.6M | $0 | $22.7M |
Every number comes from PETMED EXPRESS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.